Type 1 Diabetes

In some cases, however, the rate of decline is no different than that of the general population, according to new research.

All patients said insulin pump therapy helped their diabetes management related to exercise.

The group noted that this transformation should affect changes at every level, including at the individual level during patient visits, at the organization level in how clinical encounters are organized, and at the national level in both policies and guidelines for type 1 diabetes (T1D).

The new findings come from a 15-year study examining the natural course of C-peptide in children and adolescents with type 1 diabetes (T1D).

The most popular type 1 diabetes articles published in 2021 included new research on screening and updated coverage policy.

Results of a prospective study revealed several endothelial markers are associated with kidney dysfunction among children with type 1 diabetes.

Cynthia Rice, MPP, JDRF chief mission strategy officer, explains how Build Back Better would affect the cost of insulin.

Writing in The Lancet, researchers discuss disparities in type 1 diabetes care on the 100th anniversary of the discovery of insulin.

Findings of a small study conducted in Brazil indicate exercise prescribed to patients with type 1 diabetes (T1D) may need to be tailored based on sex.

Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, explains why clinical trials need to be inclusive and how the Health Equity Now initiative is working to recruit more diverse populations with diabetes.

Research presented at Kidney Week 2021 suggests sodium-glucose co-transporter 2 inhibitors may show beneficial cardiovascular (CV) and kidney effects among patients with type 1 diabetes.

In an effort to improve glycemic outcomes among patients with type 1 diabetes (T1D), researchers created an electronic health record (EHR) workflow to measure self-management habits.

Researchers found individuals with type 1 diabetes and neuropathy exhibit altered gray matter volume and cortical thickness compared with healthy controls.

Robert A. Gabbay, MD, PhD, the chief science and medical officer at the American Diabetes Association (ADA), discusses the most important takeaways from recent guidance on type 1 diabetes from the ADA and European Association for the Study of Diabetes (EASD).

Researchers in Poland examined the impact of vitamin D deficiency on patients with type 1 diabetes undergoing pancreas transplants.

Researchers highlighted the beneficial effects of breastfeeding on mitigating type 1 diabetes (T1D) risk.

Camillo Ricordi, MD, FNAI, outlines what needs to happen next in the islet transplantation field.

Researchers conducted a randomized clinical trial to test the efficacy of a hybrid closed-loop (HCL) system among pediatric patients with type 1 diabetes (T1D).

Camillo Ricordi, MD, FNAI, explains how the outdated FDA classification of islets as cellular transplants has hindered progress in this field for patients with type 1 diabetes.

Leslie Eiland, MD, describes the importance of learning from the COVID-19 pandemic when it comes to ensuring continuous care for those with type 1 diabetes (T1D) during future pandemics.

Throughout, the guidance from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) calls for respecting the patient’s choices, including the fact that not all patients prefer insulin pumps or can afford them.

Results of a 15-year cohort study found waist to height ratio was associated with increased risks of severe diabetic eye disease among individuals with type 1 diabetes.

Ezio Bonifacio, PhD, addresses barriers inhibiting widespread screening for type 1 diabetes (T1D), and offers insights on whether all individuals should be screened, or only those known to be at genetic risk for the disease.

A team of Australian researchers created and validated a model that may boost efficiency of type 1 diabetes (T1D) progression screening.

Camillo Ricordi, MD, FNAI, discusses some of the potential risks faced by patients with type 1 diabetes who undergo islet transplantation.

Leslie Eiland, MD, offers insights on whether use of certain technologies among patients with type 1 diabetes (T1D) will continue after the pandemic ends.

Results of a Swedish retrospective cohort study showed reduced rates of type 1 diabetes-related amputations over the past 2 decades.

Results of an Australian study highlight the changes that occur in the gut microbiome of pregnant patients with type 1 diabetes.

Aleksandar Kostic, PhD, an assistant professor of microbiology at Harvard Medical School, outlines what needs to happen next in his research developing a type 1 diabetes (T1D) vaccine.

Findings indicate that youth with type 1 diabetes may benefit from limiting fat intake.